CASP3 and glioblastoma: In GBM, a recent study about the mechanism of the first‐line chemotherapeutic agent temozolomide suggests that it promotes apoptosis in GBM cells by upregulating cation‐transport regulatory protein 1 to activate CASP3/9.47